ReleaseWire Connect

Latest industry research report on: Global RNAi for Therapeutic Consumption Market 2016: Industry Research, Size, Shares, Key Trends, Demand, Analysis, Performance, Growth, Segmentation, Parameters, Consumption and Prospects to 2021

The global Blood Plasma Derivatives market is segmented on the basis of type, application and geography. On the basis of type, the market is segmented into, Fresh Frozen Plasma (FFP), Intravenous immunoglobulin (IVIG), Albumin, Factor VIII, Factor IX and Other components. The market, on the basis of application is segmented into Hemophilia A, Hemophilia B, Von Willebrand Disease and Other Factor Deficiencies. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.

The global Incretin-Based Drugs market is segmented on the basis of drug type, formulation, and geography. On the basis of drug type, market is further segmented into Glucagon-like peptide-1 receptor (GLP-1) agonists and Dipeptidyl Peptidase-4 (DPP-4) inhibitors. According to formulation, the market is segmented into oral and injectable drugs. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific and LAMEA.

The world IVF market accounted for $9,015 million in 2015 and is projected to garner revenues worth $17,714 million by 2022, registering a CAGR of 10.2% over the forecast period. The growth of the market is attributed to the reduced conceiving rates, delayed pregnancy, changing lifestyle conditions and fertility disorders are the major factors that drive the market growth. Other factors such as favorable reimbursement scenario and delayed parenthood opted by couples due to professional and financial constraints will also help in the growth of the market. On the other hand, barriers such as ethical concerns in particular countries with respect to IVF, high cost of the IVF procedures followed by low awareness, especially in under-developed economies such as Nigeria are likely to restrain the market growth.

The global Orthopaedic Devices market is segmented on the basis of type, and geography. According to type, the market is segmented into, Upper Extremity Devices, Lower Extremity Devices, Spine Orthopedic Devices, Arthroscopic Devices, Orthobiologics and Braces & Support Devices. The Upper Extremity Devices market is further segmented into shoulder, elbow, radius and others. Similarly, the Lower Extremity Devices market segmented into Hip, Knee, Foot Ankle and Others. Further, Spine Orthopedic Devices market is segmented into Artificial Discs, Fixation Screws, Fixation Nail/Rod, Fixation Plates and Fixation Wires. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.

The world advanced wound care market was valued at $7,117 million in 2015 and is expected to reach $12,454 million, growing at a CAGR of 8.3% during 2016-2022. Market growth is attributed to the rapid increase in the incidence of chronic diseases such as diabetes, changing lifestyle factors, and attempts to reduce the duration of hospital stays to limit the surgical costs. In addition, the demand for advanced wound care market is driven by favorable reimbursement scenario, increasing healthcare expenditure by the government, and rising inclination towards products that enhance therapeutic outcomes. However, high cost of advanced wound care products coupled with low awareness, especially in underdeveloped countries such as Nigeria, Afghanistan, and Bhutan, are expected to restrain the market growth.

The global Blood Testing Technologies market is segmented on the basis of type, technology, end user and geography. On the basis of type, the market is segmented into Complete Blood Count (CBC), Basic Metabolic Panel (BMP) such as blood glucose test, electrolyte test and kidney test; blood enzyme tests such as Troponin and Creatine Kinase; tests to assess heart disease risk such as lipoprotein panel and cholesterol test and blood clotting tests; and others such as Erythrocyte Sedimentation Rate (ESR). On the basis of technology, the market is segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescent immunoassay (CLIA), Radioimmunoprecipitation assay (RIPA), Nucleic Acid Amplification Test (NAAT), Polymerase Chain Reaction (PCR), Transcription-mediated Amplification (TMA), Enzyme Immunoassay (EIA), Immunofluorescence Assay (IFA), Next Generation Sequencing (NGS) and Western Blot Test.

Latest industry research report on Cosmetics (makeup or beauty products) are mixtures of different chemical compounds generally used to enhance the appearance or odor of the human body. The cosmetics products that are predominantly available and used by individuals are sun care, skin care, hair care, deodorants, makeup & color cosmetics, and fragrances. These products are offered primarily through retail stores and online portals. The world cosmetics market is expected to grow at a CAGR of 4.3% from 2016 to 2022.

The global Renal Biomarkers market is segmented on the basis of marker type, assay platform, application and geography. On the basis of marker type, the market is segmented into Creatinine, Blood urea nitrogen (BUN), Cystatin C, Neutrophil gelatinise-associated lipocalin (NGAL). It is further segmented into other markers such as N-Acetyl-?-D-Glucosaminidase (NAG), Kidney Injury Molecule 1 (Kim1), TIMP-2, L-FABP, Interleukin-18 and Clusterin. The market is segmented on the basis of assay platform type into, Enzyme Linked Immunosorbent Assay (ELISA) and Turbidimetric Immunoassay which includes Particle-Enhanced Turbidimetric Immunoassay (PETIA). The market further segments into other assay types such as Chemiluminescent Immunoassay (CLIA) and fluorescence immunoassay. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.

Latest industry research report on Hyperscale data centers are implemented across various industries, namely, IT & telecom, banking, financial services and insurance (BFSI), government utilities, healthcare, energy, manufacturing, and others. IT strongly supports the growth of the banking sector, thereby enhancing the economic growth. Hyperscale data centers improve the competitive efficiency of the banking sector. The increasing adoption of hyperscale data center in BFSI application is expected to generate maximum revenue by 2022. In addition, in the manufacturing industry, huge amount of data is generated on the operation and shop floor, which can be analyzed to enhance the production practices. Thus, the manufacturing sector is expected to be the fastest growing application sector, with a rapid CAGR of 23.7% over the analysis period.